✦ LIBER ✦
PCN92 Cost-Effectiveness of Nilotinib Versus Imatinib as First-Line Treatment for Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Russian Federation
✍ Scribed by R. Yagudina; A. Kulikov; I. Komarov
- Book ID
- 119312377
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 60 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.